138
Alliance Growers Corp.
Dennis Petke, President & CEO (ACG)
CannaInvestor Magazine Canada
Louis Kyron, Editor (CCIM)
CSE:ACG
OTC:ALGWF
FRA:1LA
Q A
&
CCIM: Dennis, thank you for taking time of out of your busy schedule to discuss Alliance Growers Corp.
ACG: My pleasure Louis, we appreciate the opportunity.
CCIM: It was March 2017 when I wrote about ACG and highlighted the in-progress acquisition of PharmaGreen (ACG’s share price was around $0.08). In fact, the announced transaction was in July 2016 when the share price of ACG was $0.015. From that article, Retail Investors knew that PharmaGreen owns 100% of Canna Companion Products Inc. But the synergies and benefits of ACG completing that acquisition in February go well beyond the pet care industry. Can you advise on these other benefits to ACG and therefore to investors?
ACG: The other benefits to ACG, is that Pharmagreen’s operations provide valuable knowledge in manufacturing and sales of Pet CBD hemp products and therefore an opportunity to establish a Canadian brand of CBD hemp Pet products to be manufactured and sold via the Cannabis Botany Centre, of which ACG and its investors have an equity stake of up to 30%.